Search

Your search keyword '"Jones, Jeffrey"' showing total 128 results

Search Constraints

Start Over You searched for: Author "Jones, Jeffrey" Remove constraint Author: "Jones, Jeffrey" Publisher wiley Remove constraint Publisher: wiley
128 results on '"Jones, Jeffrey"'

Search Results

4. Bisphosphonate Use May Reduce the Risk of Urolithiasis in Astronauts on Long‐Term Spaceflights

7. Bisphosphonate Use May Reduce the Risk of Urolithiasis in Astronauts on Long‐Term Spaceflights

8. A centenary for bacterial spot of tomato and pepper

13. Hyperbaric oxygen therapy accelerates wound healing in diabetic mice by decreasing active matrix metalloproteinase‐9

18. Duvelisib, an oral dual PI3K-δ,γ inhibitor, shows clinical and pharmacodynamic activity in chronic lymphocytic leukemia and small lymphocytic lymphoma in a phase 1 study

19. Evaluation of 230 patients with relapsed/refractory deletion 17p chronic lymphocytic leukaemia treated with ibrutinib from 3 clinical trials

22. A single-institution retrospective cohort study of first-line R-EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an adverse prognostic factor

24. Use of anticoagulants and antiplatelet in patients with chronic lymphocytic leukaemia treated with single-agent ibrutinib

25. High throughput quantification of apolipoproteins A‐I and B‐100 by isotope dilution MS targeting fast trypsin releasable peptides without reduction and alkylation

28. The regulation of tumor‐suppressive microRNA, miR‐126, in chronic lymphocytic leukemia

31. An engineered promoter driving expression of a microbial avirulence gene confers recognition of TAL effectors and reduces growth of diverseXanthomonasstrains in citrus

38. Externally validated predictive clinical model for untreated del(17p13.1) chronic lymphocytic leukemia patients

40. Jumping translocations, a novel finding in chronic lymphocytic leukaemia

41. The combination of milatuzumab, a humanized anti-CD74 antibody, and veltuzumab, a humanized anti-CD20 antibody, demonstrates activity in patients with relapsed and refractory B-cell non-Hodgkin lymphoma

43. Reduced occurrence of tumor flare with flavopiridol followed by combined flavopiridol and lenalidomide in patients with relapsed chronic lymphocytic leukemia (CLL)

46. Complete response to induction therapy in patients with Myc-positive and double-hit non-Hodgkin lymphoma is associated with prolonged progression-free survival

47. Flavopiridol can be safely administered using a pharmacologically derived schedule and demonstrates activity in relapsed and refractory non-Hodgkin's lymphoma

50. A pilot study using residual newborn dried blood spots to assess the potential role of cytomegalovirus and Toxoplasma gondii in the etiology of congenital hydrocephalus

Catalog

Books, media, physical & digital resources